Dual Addictions Kathleen M Carroll PhD Yale University School of Medicine - PowerPoint PPT Presentation

1 / 50
About This Presentation
Title:

Dual Addictions Kathleen M Carroll PhD Yale University School of Medicine

Description:

A great deal of time spent on use of the substance or getting over its effects ... based training in CBT: CBT4CBT 'All comers': few restriction on participation, only ... – PowerPoint PPT presentation

Number of Views:47
Avg rating:3.0/5.0
Slides: 51
Provided by: kathleen51
Category:

less

Transcript and Presenter's Notes

Title: Dual Addictions Kathleen M Carroll PhD Yale University School of Medicine


1
Dual AddictionsKathleen M Carroll PhDYale
University School of Medicine
2
(No Transcript)
3
Overview
  • Definitions and terms
  • Epidemiology Rates and risks
  • Onset Gateways and destinations
  • Treatments Everything we dont know

4
(No Transcript)
5
Terms
  • Comorbidity Co-occurrence of two conditions or
    disorders
  • Dual diagnosis Co-occurrence of alcohol/drug
    use disorder and another psychiatric disorder
    (heterotypic comorbidity)
  • Homotypic comorbidity Co-occurrence of
    disorders within a diagnostic grouping (e.g.,
    substance use disorders)

6
Major US epidemiologic surveys
7
National Epidemiologic Survey on Alcohol and
Related Conditions (NESARC)
  • Previous surveys in US, Canada, Australia confirm
    probabilities of alcohol use disorder rise with
    drug use disorder visa versa
  • Only NESARC diagnosis specific (multiple types of
    drugs rather than lumping)
  • Includes data on help seeking
  • Focus on 12-month (current), rather than lifetime
    disorders
  • Oversampling of African Americans and Hispanics

8
DSM-IV Substance Dependence
  • Maladaptive use leading to clinically significant
    impairment or distress, shown by 3 of the
    following in the same 12-month period
  • Use of the substance more or longer than intended
  • Persistent desire or unsuccessful efforts to cut
    down or stop
  • A great deal of time spent on use of the
    substance or getting over its effects
  • Important activities given up or reduced because
    of use
  • Continued use despite knowledge of a serious
    physical or psychological problem
  • Tolerance
  • Withdrawal, or use to avoid withdrawal

9
(No Transcript)
10
DSM-IV Substance Abuse
  • Not dependent, and maladaptive use leading to
    clinically significant impairment or distress,
    shown by 1 of the following
  • Continued use despite social/interpersonal
    problems
  • Hazardous use (e.g., driving when impaired by
    alcohol)
  • Frequent use leading to failure to function in
    major roles
  • Legal problems

11
(No Transcript)
12
NESARC 12-month prevalence rates
Stinson et al, (2005) DAD
13
12-month prevalence Drug use disorders
Stinson et al, (2005) DAD
14
Demographics
  • Users of alcohol drugs more likely to be
  • Male (74)
  • Younger (18-29) (65)
  • Never married (63)
  • Similar to drug-only with respect to education,
    ethnicity, income

15
(No Transcript)
16
Rates of alcohol use disorders among those with
specific drug use disorders NESARC
17
Alcohol use among those with specific drug use
disorders and visa-versa
18
Comorbidity NESARC
Stinson et al, (2005) DAD
19
12-month prevalence treatment seeking by
disorder NESARC
Stinson et al, (2005) DAD
20
12-month prevalence treatment seeking by
disorder NESARC
21
Factors associated with multiple substance use
  • Retention of use through gateway progression
  • Pharmacologic effects of combinations, including
    modulation, treatment of withdrawal and
    uncomfortable effects
  • Genetic evidence of common mechanisms,
    vulnerability in some families
  • Availability, market trends

22
Gateway pattern of drug initiation Kandel et al
Cigarettes
Alcohol
Cannabis
NCS-R Only 5.2 Violate this pattern
Other illicit
23
Risk of developing disorder, given use
Anthony et al. 1994, Comparative epidemiology, NCS
24
NESARC Hazard rates for alcohol and drug use
disorders
Hasin et al., 2007 Arch Gen Psychiatry
Compton et al. 2007 Arch Gen Psychiatry
25
(No Transcript)
26
Drug-alcohol comorbidity associated with
  • Earlier onset
  • Higher severity
  • Higher psychiatric comorbidity
  • Higher rates of treatment seeking
  • Higher rates of dropout once in treatment
  • Less socioeconomic support
  • Poorer treatment outcome

27
(No Transcript)
28
Limited research on treatment of homotypic
comorbidity
  • Users of multiple substances usually excluded
    from treatment research
  • Difficulty in meeting needs of heterogeneous
    populations in single trial
  • Complexity of assessment (time frame,
    availability of biologic indicators, time)
  • Complexity of targeting multiple substances
    simultaneously (licit, illicit)Safety and
    compliance concerns, especially in pharmacologic
    trials
  • Pharmacologic specificity

Rounsaville et al, 2003
29
(No Transcript)
30
Available pharmacotherapies for substance use
disorders
31
Emerging pharmacologic strategies for homotypic
comorbidity
32
(No Transcript)
33
Original rationale for disulfiram as treatment
for cocaine users
  • Clinical observation of high levels of concurrent
    alcohol-cocaine use (60-70 of patients)
  • Rationale Reducing alcohol use may reduce
    concurrent cocaine use
  • Better ability to utilize coping skills (Marlatt
    et al)
  • Alcohol powerful conditioned cue (Higgins et al)
  • Cocaethylene (Jatlow, McCance)

34
Open outpatient study, cocaine-alcohol users
attaining 3 weeks abstinence
Carroll et al., 1998
35
Double blind trial of disulfiram for cocaine
dependence in methadone maintenance N67
Petrakis et al 2000
36
Randomized outpatient clinical trial
Disulfiram, CBT, and IPT, N121
Carroll et al., 2004
37
Cocaine outcomes for those who did NOT meet
criteria for alcohol abuse or dependence (n58)
38
Behavioral therapy studies of alcohol-drug users
39
Behavioral therapies tend to be effective across
types of substance use
40
Clinical Trials Network17 Current Nodes, gt200
CTPs
41
Clinical Trials Network MET Trials Participant
Characteristics
  • Mean age 35
  • 29 female (ltMI)
  • 42 Caucasian (ltMI)
  • 12 years of education
  • 28 mandated or legal referral
  • Primary substance use problem
  • Alcohol 29 (ltMI)
  • Marijuana 16
  • Cocaine 23 (gtMI)
  • Methamphetamine 4 (ltMI)
  • Opioids 9
  • Benzodiazepenes 1

Ball et al., 2007
42
CTN MET/MI studies Design
43
CTN MET longitudinal outcomes
Ball et al.., 2007
44
CTN MET/MI studies Outcomes for alcohol subgroups
45
CBT 4 CBTComputer Based Therapy/CBT
  • 6 modules, 1 hour each, high flexibility
  • Highly user friendly, no text to read, linear
    navigation
  • Video examples of characters struggling real life
    situations
  • Multimedia presentation of skills
  • Repeat movie with character using skills
  • to change ending
  • Interactive exercises, quizzes
  • Multiple examples of
  • homework

46
Computer-based training in CBT CBT4CBT
  • All comers few restriction on participation,
    only require some drug use in past 30 days
  • 43 female
  • 45 African American, 12 Hispanic
  • 23 employed
  • 37 on probation/parole
  • 59 primary cocaine problem, 18 alcohol, 16
    opioids, 7 marijuana
  • 79 users of more than one drug or alcohol

Carroll et al., in press, Am J Psychiatry
47
Primary outcomes, 8 weeksCBTTAU versus TAU
Carroll et al., in press, Am J Psychiatry
48
(No Transcript)
49
Treatment of Dual AddictionsGeneral strategies
  • Target, treat most severe disorder and any
    requiring detoxification first
  • Utilize pharmacotherapies when available
  • Attend to psychiatric and medical comorbidity
  • Frequent monitoring, chronic care model
  • Sequential targeting may be important for some
    treatments (eg. contingency management)

50
I wonder why were not getting any new converts.
Write a Comment
User Comments (0)
About PowerShow.com